Premium
Geography: an increasingly important variable in prostate cancer clinical trials
Author(s) -
Sartor Oliver,
Pal Sumanta Kumar,
Hermanson Terhi,
Bennett Charles L.
Publication year - 2015
Publication title -
bju international
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1111/bju.12930
Subject(s) - enzalutamide , cohort , docetaxel , medicine , placebo , prostate cancer , european union , post hoc analysis , clinical trial , oncology , cancer , pathology , androgen receptor , alternative medicine , business , economic policy